Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PYRAZOLOPYRAZINE-LINKED TRICYCLIC COMPOUND AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/156765
Kind Code:
A1
Abstract:
Disclosed is a pyrazolopyrazine-linked tricyclic compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound has inhibitory activity on protein tyrosine phosphatase SHP2 and can be used to treat diseases related to SHP2, such as lung cancer.

Inventors:
FU ZHIFEI (CN)
LUO MIAORONG (CN)
SHUAI BIN (CN)
ZHANG YANG (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2022/073167
Publication Date:
July 28, 2022
Filing Date:
January 21, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D487/04; A61K31/4985; A61P35/00; C07D491/107; C07D491/20
Domestic Patent References:
WO2019183367A12019-09-26
WO2021148010A12021-07-29
WO2018172984A12018-09-27
WO2016203404A12016-12-22
Foreign References:
CN111138412A2020-05-12
CN111704611A2020-09-25
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: